Comparison Between SGLT2 Inhibitors and Pioglitazone as Additions to Insulin Therapy in Type 2 Diabetes: A Systematic Review With an Indirect Comparison Meta-Analysis

Journal of Diabetes Investigation - Australia
doi 10.1111/jdi.12787

Related search